This report aims to provide a comprehensive presentation of the global market for Approved COVID-19 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Approved COVID-19 Vaccines. This report contains market size and forecasts of Approved COVID-19 Vaccines in global, including the following market information:
Global Approved COVID-19 Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Approved COVID-19 Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Approved COVID-19 Vaccines companies in 2022 (%)
The global Approved COVID-19 Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Component Viral Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Approved COVID-19 Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Approved COVID-19 Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Type, 2022 (%)
Component Viral Vaccines
Whole Virus Vaccines
Global Approved COVID-19 Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Elderly
Global Approved COVID-19 Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Approved COVID-19 Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Approved COVID-19 Vaccines revenues share in global market, 2022 (%)
Key companies Approved COVID-19 Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Approved COVID-19 Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson?Johnson
Heat Biologics
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Approved COVID-19 Vaccines, market overview.
Chapter 2: Global Approved COVID-19 Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Approved COVID-19 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Approved COVID-19 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Approved COVID-19 Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Approved COVID-19 Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Approved COVID-19 Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Approved COVID-19 Vaccines Overall Market Size
2.1 Global Approved COVID-19 Vaccines Market Size: 2022 VS 2029
2.2 Global Approved COVID-19 Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Approved COVID-19 Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Approved COVID-19 Vaccines Players in Global Market
3.2 Top Global Approved COVID-19 Vaccines Companies Ranked by Revenue
3.3 Global Approved COVID-19 Vaccines Revenue by Companies
3.4 Global Approved COVID-19 Vaccines Sales by Companies
3.5 Global Approved COVID-19 Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Approved COVID-19 Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Approved COVID-19 Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Approved COVID-19 Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Approved COVID-19 Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Approved COVID-19 Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Approved COVID-19 Vaccines Market Size Markets, 2022 & 2029
4.1.2 Component Viral Vaccines
4.1.3 Whole Virus Vaccines
4.2 By Type - Global Approved COVID-19 Vaccines Revenue & Forecasts
4.2.1 By Type - Global Approved COVID-19 Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Approved COVID-19 Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Approved COVID-19 Vaccines Sales & Forecasts
4.3.1 By Type - Global Approved COVID-19 Vaccines Sales, 2018-2023
4.3.2 By Type - Global Approved COVID-19 Vaccines Sales, 2024-2029
4.3.3 By Type - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Approved COVID-19 Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Approved COVID-19 Vaccines Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.1.4 Elderly
5.2 By Application - Global Approved COVID-19 Vaccines Revenue & Forecasts
5.2.1 By Application - Global Approved COVID-19 Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Approved COVID-19 Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Approved COVID-19 Vaccines Sales & Forecasts
5.3.1 By Application - Global Approved COVID-19 Vaccines Sales, 2018-2023
5.3.2 By Application - Global Approved COVID-19 Vaccines Sales, 2024-2029
5.3.3 By Application - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Approved COVID-19 Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Approved COVID-19 Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Approved COVID-19 Vaccines Revenue & Forecasts
6.2.1 By Region - Global Approved COVID-19 Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Approved COVID-19 Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Approved COVID-19 Vaccines Sales & Forecasts
6.3.1 By Region - Global Approved COVID-19 Vaccines Sales, 2018-2023
6.3.2 By Region - Global Approved COVID-19 Vaccines Sales, 2024-2029
6.3.3 By Region - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Approved COVID-19 Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Approved COVID-19 Vaccines Sales, 2018-2029
6.4.3 US Approved COVID-19 Vaccines Market Size, 2018-2029
6.4.4 Canada Approved COVID-19 Vaccines Market Size, 2018-2029
6.4.5 Mexico Approved COVID-19 Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Approved COVID-19 Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Approved COVID-19 Vaccines Sales, 2018-2029
6.5.3 Germany Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.4 France Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.5 U.K. Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.6 Italy Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.7 Russia Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Approved COVID-19 Vaccines Market Size, 2018-2029
6.5.9 Benelux Approved COVID-19 Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Approved COVID-19 Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Approved COVID-19 Vaccines Sales, 2018-2029
6.6.3 China Approved COVID-19 Vaccines Market Size, 2018-2029
6.6.4 Japan Approved COVID-19 Vaccines Market Size, 2018-2029
6.6.5 South Korea Approved COVID-19 Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Approved COVID-19 Vaccines Market Size, 2018-2029
6.6.7 India Approved COVID-19 Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Approved COVID-19 Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Approved COVID-19 Vaccines Sales, 2018-2029
6.7.3 Brazil Approved COVID-19 Vaccines Market Size, 2018-2029
6.7.4 Argentina Approved COVID-19 Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, 2018-2029
6.8.3 Turkey Approved COVID-19 Vaccines Market Size, 2018-2029
6.8.4 Israel Approved COVID-19 Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Approved COVID-19 Vaccines Market Size, 2018-2029
6.8.6 UAE Approved COVID-19 Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Moderna
7.1.1 Moderna Company Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna Approved COVID-19 Vaccines Major Product Offerings
7.1.4 Moderna Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Moderna Key News & Latest Developments
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Company Summary
7.2.2 CanSino Biologicals Business Overview
7.2.3 CanSino Biologicals Approved COVID-19 Vaccines Major Product Offerings
7.2.4 CanSino Biologicals Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 CanSino Biologicals Key News & Latest Developments
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Company Summary
7.3.2 Inovio Pharmaceuticals Business Overview
7.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Major Product Offerings
7.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Inovio Pharmaceuticals Key News & Latest Developments
7.4 Shenzhen Geno-Immune Medical Institute
7.4.1 Shenzhen Geno-Immune Medical Institute Company Summary
7.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
7.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Major Product Offerings
7.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Shenzhen Geno-Immune Medical Institute Key News & Latest Developments
7.5 GlaxoSmithKine
7.5.1 GlaxoSmithKine Company Summary
7.5.2 GlaxoSmithKine Business Overview
7.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Major Product Offerings
7.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKine Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Approved COVID-19 Vaccines Major Product Offerings
7.6.4 Pfizer Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Company Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson Approved COVID-19 Vaccines Major Product Offerings
7.7.4 Johnson?Johnson Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Johnson?Johnson Key News & Latest Developments
7.8 Heat Biologics
7.8.1 Heat Biologics Company Summary
7.8.2 Heat Biologics Business Overview
7.8.3 Heat Biologics Approved COVID-19 Vaccines Major Product Offerings
7.8.4 Heat Biologics Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Heat Biologics Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Approved COVID-19 Vaccines Major Product Offerings
7.9.4 Sanofi Approved COVID-19 Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
8 Global Approved COVID-19 Vaccines Production Capacity, Analysis
8.1 Global Approved COVID-19 Vaccines Production Capacity, 2018-2029
8.2 Approved COVID-19 Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Approved COVID-19 Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Approved COVID-19 Vaccines Supply Chain Analysis
10.1 Approved COVID-19 Vaccines Industry Value Chain
10.2 Approved COVID-19 Vaccines Upstream Market
10.3 Approved COVID-19 Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Approved COVID-19 Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Approved COVID-19 Vaccines in Global Market
Table 2. Top Approved COVID-19 Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Approved COVID-19 Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Approved COVID-19 Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Approved COVID-19 Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Approved COVID-19 Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Approved COVID-19 Vaccines Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Approved COVID-19 Vaccines Product Type
Table 9. List of Global Tier 1 Approved COVID-19 Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Approved COVID-19 Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Approved COVID-19 Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Approved COVID-19 Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Approved COVID-19 Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Approved COVID-19 Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Approved COVID-19 Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Approved COVID-19 Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Approved COVID-19 Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Approved COVID-19 Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Approved COVID-19 Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Approved COVID-19 Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Approved COVID-19 Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Approved COVID-19 Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Approved COVID-19 Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Approved COVID-19 Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Approved COVID-19 Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, (K Units), 2024-2029
Table 46. Moderna Company Summary
Table 47. Moderna Approved COVID-19 Vaccines Product Offerings
Table 48. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Moderna Key News & Latest Developments
Table 50. CanSino Biologicals Company Summary
Table 51. CanSino Biologicals Approved COVID-19 Vaccines Product Offerings
Table 52. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CanSino Biologicals Key News & Latest Developments
Table 54. Inovio Pharmaceuticals Company Summary
Table 55. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Offerings
Table 56. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Inovio Pharmaceuticals Key News & Latest Developments
Table 58. Shenzhen Geno-Immune Medical Institute Company Summary
Table 59. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Offerings
Table 60. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Shenzhen Geno-Immune Medical Institute Key News & Latest Developments
Table 62. GlaxoSmithKine Company Summary
Table 63. GlaxoSmithKine Approved COVID-19 Vaccines Product Offerings
Table 64. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKine Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Approved COVID-19 Vaccines Product Offerings
Table 68. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Johnson?Johnson Company Summary
Table 71. Johnson?Johnson Approved COVID-19 Vaccines Product Offerings
Table 72. Johnson?Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Johnson?Johnson Key News & Latest Developments
Table 74. Heat Biologics Company Summary
Table 75. Heat Biologics Approved COVID-19 Vaccines Product Offerings
Table 76. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Heat Biologics Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Approved COVID-19 Vaccines Product Offerings
Table 80. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Approved COVID-19 Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Approved COVID-19 Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Approved COVID-19 Vaccines Production by Region, 2018-2023 (K Units)
Table 85. Global Approved COVID-19 Vaccines Production by Region, 2024-2029 (K Units)
Table 86. Approved COVID-19 Vaccines Market Opportunities & Trends in Global Market
Table 87. Approved COVID-19 Vaccines Market Drivers in Global Market
Table 88. Approved COVID-19 Vaccines Market Restraints in Global Market
Table 89. Approved COVID-19 Vaccines Raw Materials
Table 90. Approved COVID-19 Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical Approved COVID-19 Vaccines Downstream
Table 92. Approved COVID-19 Vaccines Downstream Clients in Global Market
Table 93. Approved COVID-19 Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Approved COVID-19 Vaccines Segment by Type in 2022
Figure 2. Approved COVID-19 Vaccines Segment by Application in 2022
Figure 3. Global Approved COVID-19 Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Approved COVID-19 Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Approved COVID-19 Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Approved COVID-19 Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Approved COVID-19 Vaccines Revenue in 2022
Figure 9. By Type - Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Approved COVID-19 Vaccines Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Approved COVID-19 Vaccines Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Approved COVID-19 Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 23. US Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 37. China Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Approved COVID-19 Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Approved COVID-19 Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Approved COVID-19 Vaccines by Region, 2022 VS 2029
Figure 54. Approved COVID-19 Vaccines Industry Value Chain
Figure 55. Marketing Channels
